1-iodo-3-isobutoxybenzene | 1249463-55-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-iodo-3-isobutoxybenzene
• 英文别名: 1-Iodo-3-(2-methylpropoxy)benzene
• CAS: 1249463-55-5
• 化学式: C₁₀H₁₃IO
• mdl: MFCD14644567
• 分子量: 276.117
• InChiKey: JJKOYSGESJHTKO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-iodo-3-isobutoxybenzene 在 aluminum oxide 、 1,10-菲罗啉 、 silver trifluoromethanesulfonate 、 间氯过氧苯甲酸 作用下， 以 乙醚 、 正己烷 、 二氯甲烷 、 1,2-二氯乙烷 为溶剂， 反应 26.0h， 生成 3-isobutoxyphenol
  参考文献：
  名称：

  银催化非反应性羧酸酯的偶联：α-氟化 O-芳基酯的合成

  摘要：

  由于其低反应活性，α-氟化芳基酯在通过 α-氟化羧酸酯的O-芳基化合成中提出了挑战。通过将银催化剂与芳基（三甲氧基苯基）碘鎓甲苯磺酸盐组合以得到α-氟化芳基酯，解决了这一限制。我们设想催化系统涉及通过银（I）盐氧化产生的高价芳基银物质。本方法提供了各种α-氟化芳基酯（包括药物衍生物的氟化类似物）的合成方案。

  DOI：

  10.1021/acs.orglett.4c01731
• 作为产物：
  描述：

  溴代异丁烷 、 3-碘苯酚 在 potassium carbonate 作用下， 以 丙酮 为溶剂， 反应 18.0h， 以46%的产率得到1-iodo-3-isobutoxybenzene
  参考文献：
  名称：

  Design, Synthesis, and Biological Activity of a Novel Series of Human Sirtuin-2-Selective Inhibitors

  摘要：

  Selective inhibitors of human sirtuin 2 (SIRT2), a deacetylase, are candidate therapeutic agents for neurodegenerative diseases such as Parkinson's disease and Huntington's disease as well as potential tools for elucidating the biological functions of SIRT2. On the basis of homology models of SIRT1 and SIRT2, we designed and prepared a series of 2-anilinobenzamide analogues. Enzyme assays using recombinant SIRT1 and SIRT2 revealed that 3'-phenethyloxy-2-anilinobenzamide analogues such as 33a and 33i are potent and selective SIRT2 inhibitors, showing more than 3.5-fold greater SIRT2-inhibitory activity and more than 35-fold greater SIRT2-selectivity compared with AGK2 (3), a previously reported SIRT2-selective inhibitor. Compound 33a also induced a dose-dependent selective increase of alpha-tubulin acetylation in human colon cancer HCT116 cells, indicating selective inhibition of SIRT2 in the cells. These 3'-phenethyloxy-2-anilinobenzamide derivatives represent an entry into a new class of SIRT2-selective inhibitors.

  DOI：

  10.1021/jm3002108

文献信息

• Design, Synthesis, and Biological Activity of a Novel Series of Human Sirtuin-2-Selective Inhibitors
  作者：Takayoshi Suzuki、Mohammed Naseer Ahmed Khan、Hideyuki Sawada、Erika Imai、Yukihiro Itoh、Katsura Yamatsuta、Natsuko Tokuda、Jun Takeuchi、Takuya Seko、Hidehiko Nakagawa、Naoki Miyata

  DOI：10.1021/jm3002108

  日期：2012.6.28

  Selective inhibitors of human sirtuin 2 (SIRT2), a deacetylase, are candidate therapeutic agents for neurodegenerative diseases such as Parkinson's disease and Huntington's disease as well as potential tools for elucidating the biological functions of SIRT2. On the basis of homology models of SIRT1 and SIRT2, we designed and prepared a series of 2-anilinobenzamide analogues. Enzyme assays using recombinant SIRT1 and SIRT2 revealed that 3'-phenethyloxy-2-anilinobenzamide analogues such as 33a and 33i are potent and selective SIRT2 inhibitors, showing more than 3.5-fold greater SIRT2-inhibitory activity and more than 35-fold greater SIRT2-selectivity compared with AGK2 (3), a previously reported SIRT2-selective inhibitor. Compound 33a also induced a dose-dependent selective increase of alpha-tubulin acetylation in human colon cancer HCT116 cells, indicating selective inhibition of SIRT2 in the cells. These 3'-phenethyloxy-2-anilinobenzamide derivatives represent an entry into a new class of SIRT2-selective inhibitors.
• 10.1021/acs.orglett.4c01731
  作者：Kikushima, Kotaro、Komiyama, Keina、Umekawa, Narumi、Yamada, Kohei、Kita, Yasuyuki、Dohi, Toshifumi

  DOI：10.1021/acs.orglett.4c01731

  日期：——

  α-Fluorinated aryl esters pose a challenge in synthesis via O-arylation of α-fluorinated carboxylates owing to their low reactivities. This limitation has been addressed by combining a silver catalyst with aryl(trimethoxyphenyl)iodonium tosylates to access α-fluorinated aryl esters. We envision that the catalytic system involves high-valent aryl silver species generated via the oxidation of silver(I)

  由于其低反应活性，α-氟化芳基酯在通过 α-氟化羧酸酯的O-芳基化合成中提出了挑战。通过将银催化剂与芳基（三甲氧基苯基）碘鎓甲苯磺酸盐组合以得到α-氟化芳基酯，解决了这一限制。我们设想催化系统涉及通过银（I）盐氧化产生的高价芳基银物质。本方法提供了各种α-氟化芳基酯（包括药物衍生物的氟化类似物）的合成方案。